Disclosing APOL1 genetic testing results to patients of African ancestry with hypertension and to their clinicians was associated with a greater reduction in blood pressure, kidney disease screening, and self-reported behavior changes in those with high-risk APOL1 genotypes. Here, APOL1 is linked to hypertensive disorder.